Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...
Truist initiated coverage of BioNTech (BNTX) with a Buy rating and $172 price target BioNTech is an oncology company “at heart, even though it ...
Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback